Literature DB >> 10811703

Manometric investigation of anorectal function in early and late stage Parkinson's disease.

G Bassotti1, D Maggio, E Battaglia, O Giulietti, F Spinozzi, G Reboldi, A M Serra, G Emanuelli, G Chiarioni.   

Abstract

Abnormal gastrointestinal function is relatively frequent in Parkinson's disease, and constipation is a disturbing symptom in many patients. However, it remains to be established whether anorectal abnormalities are characteristic of the late stages of the disease. Clinical and anorectal manometric function were investigated in groups of early and late stage parkinsonian patients. Thirty one patients (19 men, 12 women, age range 22 to 89 years) entered the study. The disease severity was assessed by Hoehn and Yahr staging: there were four (12.9%) stage I, seven (22.6%) stage II, 10 (32.2%) stage III, and 10 (32.2%) stage IV patients. Anorectal variables were measured by standard manometric equipment and techniques. Values obtained in early stage patients (Hoehn and Yahr stage I and II) were compared with those obtained in late stage patients (Hoehn and Yahr stage III and IV). Overall, more than 70% of patients complained of chronic constipation, with chronic laxative use reported in more than 30%. Late stage patients were slightly older than their early stage counterparts. Pelvic floor dyssynergia was documented in more than 60% of patients. Manometric variables were not different in the two groups. In conclusion, defecatory dysfunction is frequent in Parkinson's disease, it is not confined to late stage patients, and it is found early in the course of the disease. This has potential implications for a targeted therapeutic approach.

Entities:  

Mesh:

Year:  2000        PMID: 10811703      PMCID: PMC1736944          DOI: 10.1136/jnnp.68.6.768

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

Review 1.  Constipation in neurological diseases.

Authors:  K Winge; D Rasmussen; L M Werdelin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

Review 2.  Gut dysfunction in Parkinson's disease.

Authors:  Adreesh Mukherjee; Atanu Biswas; Shyamal Kumar Das
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 3.  Early diagnosis of Parkinson's disease.

Authors:  Jörg Spiegel; Alexander Storch; Wolfgang H Jost
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

Review 4.  Understanding and treating refractory constipation.

Authors:  Gabrio Bassotti; Corrado Blandizzi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

5.  Skin biopsy for assessment of autonomic denervation in Parkinson's disease.

Authors:  R Dabby; R Djaldetti; M Shahmurov; T A Treves; B Gabai; E Melamed; M Sadeh; I Avinoach
Journal:  J Neural Transm (Vienna)       Date:  2006-07-13       Impact factor: 3.575

Review 6.  Behavioral phenotyping of mouse models of Parkinson's disease.

Authors:  Tonya N Taylor; James G Greene; Gary W Miller
Journal:  Behav Brain Res       Date:  2010-03-06       Impact factor: 3.332

7.  Manometric assessment of idiopathic megarectum in constipated children.

Authors:  Giuseppe Chiarioni; Giuseppe de Roberto; Alessandro Mazzocchi; Antonio Morelli; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

Review 8.  Sphincter EMG as a diagnostic tool in autonomic disorders.

Authors:  Ryuji Sakakibara; Tomoyuki Uchiyama; Tomonori Yamanishi; Masahiko Kishi
Journal:  Clin Auton Res       Date:  2008-09-08       Impact factor: 4.435

Review 9.  [Gastrointestinal dysfunction in idiopathic Parkinson's disease].

Authors:  K Del Tredici; W H Jost
Journal:  Nervenarzt       Date:  2012-10       Impact factor: 1.214

10.  Cellular and molecular basis of chronic constipation: taking the functional/idiopathic label out.

Authors:  Gabrio Bassotti; Vincenzo Villanacci; Dragos Creţoiu; Sanda Maria Creţoiu; Gabriel Becheanu
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.